130 related articles for article (PubMed ID: 11069039)
1. Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML.
Dupont M; Jourdan E; Chiesa J
Leukemia; 2000 Nov; 14(11):2011-2. PubMed ID: 11069039
[No Abstract] [Full Text] [Related]
2. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis.
Schultheis B; Wang L; Clark RE; Melo JV
Leukemia; 2003 Oct; 17(10):2054-5. PubMed ID: 14513059
[No Abstract] [Full Text] [Related]
3. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
Inokuchi K; Futaki M; Dan K; Nomura T
Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
[TBL] [Abstract][Full Text] [Related]
4. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
[TBL] [Abstract][Full Text] [Related]
5. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Langenhuijsen MM; Ossenkoppele GJ
Leukemia; 1997 Feb; 11(2):301-5. PubMed ID: 9009097
[TBL] [Abstract][Full Text] [Related]
7. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
9. Detection of tumor-specific antigens in Philadelphia chromosome positive leukemias.
van Denderen J; ten Hacken P; Berendes P; van Ewijk W
Leuk Lymphoma; 1993; 11 Suppl 1():29-32. PubMed ID: 7504546
[TBL] [Abstract][Full Text] [Related]
10. Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106
[TBL] [Abstract][Full Text] [Related]
11. [Detection of the Mbcr/abl translocation using FISH in bone marrow samples from patients diagnosed with CML and ALL].
Vargas MT; Fernández-Novoa MC; García-Creus MD; González-Ruano J
Sangre (Barc); 1996 Oct; 41(5):399-400. PubMed ID: 9026927
[No Abstract] [Full Text] [Related]
12. Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia.
Wang L; Pearson K; Pillitteri L; Ferguson JE; Clark RE
Br J Haematol; 2002 Sep; 118(3):771-7. PubMed ID: 12181044
[TBL] [Abstract][Full Text] [Related]
13. A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course.
Byrne JL; Carter GI; Davies JM; Haynes AP; Russell NH; Cross NC
Br J Haematol; 1998 Dec; 103(3):791-4. PubMed ID: 9858233
[TBL] [Abstract][Full Text] [Related]
14. Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridization.
Martín-Subero JI; Lahortiga I; Gómez E; Ferreira C; Larrayoz MJ; Odero MD; García-Delgado M; Novo FJ; Giraldo P; Calasanz MJ
Cancer Genet Cytogenet; 2001 Mar; 125(2):167-70. PubMed ID: 11369063
[TBL] [Abstract][Full Text] [Related]
15. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome-positive thrombocythemia without features of chronic myeloid leukemia (CML) in peripheral blood.
Girodon F; Bailly F; Barry M; Favre B; Carli PM; Mugneret F; Teyssier JR; Maynadié M
Ann Hematol; 2005 Jun; 84(6):409-10. PubMed ID: 15692837
[No Abstract] [Full Text] [Related]
17. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
[TBL] [Abstract][Full Text] [Related]
18. Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood.
Pasternak G; Pasternak L
Ann Hematol; 1994 Jan; 68(1):9-14. PubMed ID: 8110881
[TBL] [Abstract][Full Text] [Related]
19. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
20. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]